The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Pharmacogenetic Testing Market During The Forecast Period 2026–2030?
The pharmacogenetic testing market has shown considerable growth in recent years. This market is expected to expand from $14.33 billion in 2025 to $16.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.7%. The historical expansion can be traced to advancements in genomic sequencing technologies, concerns over adverse drug reactions, a rising incidence of chronic diseases, decreasing genetic testing costs, and improved clinical awareness.
The pharmacogenetic testing market is poised for significant expansion in the coming years. It is projected to reach $29.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. This anticipated growth throughout the forecast period stems from factors such as the development of precision healthcare, the broader availability of direct-to-consumer testing, the integration with electronic health records, increasing regulatory assistance, and heightened investment in genomics research. Prominent trends expected in this timeframe include the rising acceptance of personalized medicine, a greater application of genetic testing in selecting drugs, the expansion of oncology and cardiology uses, a growing requirement for precision diagnostics, and the routine incorporation of pharmacogenomics into clinical practice.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp
What Underlying Factors Are Accelerating The Growth Of The Pharmacogenetic Testing Market?
The pharmacogenetic testing market is anticipated to grow, propelled by the rising demand for personalized medicine. This healthcare approach, also known as precision medicine, customizes treatments and medical decisions according to an individual’s distinct genetic, biological, and lifestyle attributes. The increasing need for personalized medicine is attributed to its ability to improve treatment results, aid in early detection, and enhance cost-effectiveness in patient care. The pharmacogenetic testing market contributes to personalized medicine by examining a person’s genetic makeup to forecast drug responses, thus facilitating optimal treatment choices and reducing the likelihood of adverse reactions. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, noted that the FDA sanctioned 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 approvals in 2022. Therefore, the escalating demand for personalized medicine is driving the expansion of the pharmacogenetic testing market.
What Market Segments Are Evaluated Within The Pharmacogenetic Testing Market?
The pharmacogenetic testing market covered in this report is segmented –
1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests
2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications
3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services
5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users
Subsegments:
1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing
2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing
3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing
4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes
What Industry Trends Are Redefining The Pharmacogenetic Testing Market?
Leading companies within the pharmacogenetics testing market are concentrating on developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing. This initiative seeks to enhance medication safety, improve treatment precision, and support personalized therapeutic decision-making. Prescription-based pharmacogenetic testing refers to genetic analyses commissioned by licensed healthcare providers to examine how an individual’s genetic makeup influences their response to specific medications, enabling clinicians to optimize drug selection and dosing while reducing the likelihood of adverse drug reactions. For instance, in May 2023, UCSF, a US-based healthcare organization, launched its pharmacogenomics testing service. This service is designed to improve the precision of medical treatments by providing healthcare professionals with genetic insights that help tailor drug therapies to each patient’s unique profile, strengthen drug efficacy, and minimize the risk of harmful side effects.
Who Are The Top Market Participants Influencing The Pharmacogenetic Testing Market?
Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC
Read the full pharmacogenetic testing market report here:
https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report
Which Region Is Projected To Dominate The Pharmacogenetic Testing Market During The Forecast Period?
Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmacogenetic Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp
Browse Through More Reports Similar to the Global Pharmacogenetic Testing Market 2026, By The Business Research Company
Neurogenetic Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report
Genetic Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report
Genetic Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model